Global Anti-Inflammatory Therapeutics Market 2014-2020 by Indication, Drug Class & Geography

Nov 16, 2015, 07:10 ET from Research and Markets

DUBLIN, Nov. 16, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/8rkdpz/world) has announced the addition of the "World Anti-Inflammatory Therapeutics Market - Opportunities and Forecasts, 2014 - 2020" report to their offering.

The global anti-inflammatory therapeutics market is expected to grow at a CAGR of 5.9% from 2015 to 2020. The anti-inflammatory biologics segment held 3/5th of overall market in 2014. The Asia Pacific market would exhibit the highest CAGR of 8.5% during the forecast period.

Inflammation is the mechanism of innate immunity, which eliminates the cause of injury. Sometimes, the body's defense system inappropriately triggers inflammation against its own cells, resulting in inflammatory autoimmune diseases. Reducing inflammation is one of the primary therapeutic strategies in acute as well as chronic diseases such as arthritis, psoriasis, and asthma. The rising incidences of autoimmune and respiratory conditions, extensive drug development pipeline, and increasing popularity of anti-inflammatory drugs with lesser side effects are the key factors driving the growth of the global anti-inflammatory therapeutics market. In addition, growing awareness about anti-inflammatory therapeutics and government initiatives, in the Asia pacific and LAMEA would further boost the market growth. However adverse effects associated with long term consumption of drugs namely NSAIDs and Corticosteroids would limit the market growth to a certain extent.

The anti-inflammatory biologics hold the largest market share in 2014 and would also exhibit highest growth rate over the forecast period. This is due to the emergence of targeted anti-inflammatory biologics and biosimilars with lesser side effects. Market share of corticosteroids is projected to decrease by 2020, primarily due to withdrawal syndromes. Among indication market, arthritis would continue to lead through 2020 due to high incidence rate and preference of anti-inflammatory biologics for the treatment of arthritis.

Key findings of the study:

- Arthritis indication was the major revenue generating segment in the global anti-inflammatory therapeutics market in 2014 followed by respiratory diseases
- Psoriasis segment is the projected to grow at a CAGR of 8.1%, fastest among all
- North America would continue to lead the market through 2020, currently accounts for about half of the global revenue
- The U.S. accounted for about 5/6th of the North America anti-inflammatory therapeutics market revenue in 2014
- Asia-Pacific is projected to be the fastest growing market

Key Topics Covered:

Chapter: 1 Introduction

Chapter: 2 Executive Summary

Chapter: 3 Market Overview

Chapter: 4 Global Anti-Inflammatory Therapeutics Market By Indication

Chapter: 5 Global Anti-Inflammatory Therapeutics Market By Drug Class

Chapter: 6 Global Anti-Inflammatory Therapeutics Market By Geography

Chapter: 7 Company Profiles

- AbbVie Inc
- Amgen Inc.
- AstraZeneca PLC.
- Eli Lily and Company
- GlaxoSmithKline plc
- Hoffmann-La Roche AG
- Johnson & Johnson
- Merck & Co.
- Novartis AG
- Pfizer Inc

For more information visit http://www.researchandmarkets.com/research/8rkdpz/world

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com